RedPath Integrated Pathology Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Employees
-
40
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$44.9M
RedPath Integrated Pathology General Information
Description
Operator of a diagnostic platform intended for early and definitive diagnosis of cancer. The company's diagnostic platform uses study and experimentation on genetic mutations to extract objective and quantitative genetic information from the most minute tissue biopsy, cytology, and fluid specimens, enabling pathologists, clinicians, and patients to resolve diagnostic dilemmas when cancers do not respond to treatments as predicted.
Contact Information
Website
www.redpathip.comCorporate Office
- 2515 Liberty Avenue
- Pittsburgh, PA 15222
- United States
Corporate Office
- 2515 Liberty Avenue
- Pittsburgh, PA 15222
- United States
RedPath Integrated Pathology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 03-Nov-2014 | $44.9M | Completed | Generating Revenue | ||
| 6. Later Stage VC | 13-May-2011 | Completed | Generating Revenue | |||
| 5. Merger/Acquisition | 26-Oct-2010 | Cancelled | Generating Revenue | |||
| 4. Early Stage VC (Series B) | 30-Apr-2008 | Completed | Startup | |||
| 3. Early Stage VC (Series A) | 20-Dec-2006 | Completed | Startup | |||
| 2. Seed Round | 09-Aug-2006 | $100K | $100K | Completed | Startup | |
| 1. Accelerator/Incubator | 28-Sep-2005 | Completed | Startup |
RedPath Integrated Pathology Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
RedPath Integrated Pathology Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
RedPath Integrated Pathology Patents
RedPath Integrated Pathology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2015017125-A2 | Methods for treating barrett's metaplasia and esophageal adenocarcinoma | Inactive | 30-Jul-2013 | ||
| WO-2015017125-A3 | Methods for treating barrett's metaplasia and esophageal adenocarcinoma | Inactive | 30-Jul-2013 | ||
| EP-1812601-A2 | Dynamic genomic deletion expansion and formulation of molecular marker panels for integrated molecular pathology diagnosis and characterization of tissue, cellular fluid, and pure fluid specimens | Inactive | 22-Oct-2004 | ||
| WO-2006047483-A2 | Dynamic genomic deletion expansion and formulation of molecular marker panels for integrated molecular pathology diagnosis and characterization of tissue, cellular fluid, and pure fluid specimens | Inactive | 22-Oct-2004 | ||
| WO-2006047483-A3 | Dynamic genomic deletion expansion and formulation of molecular marker panels for integrated molecular pathology diagnosis and characterization of tissue, cellular fluid, and pure fluid specimens | Inactive | 22-Oct-2004 | G01N33/57525 |
RedPath Integrated Pathology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
RedPath Integrated Pathology Former Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BlueTree Allied Angels | Angel Group | Minority | ||
| CID Equity | Venture Capital | Minority | ||
| Eurobio Scientific | Corporation | Minority | ||
| Golden Seeds | Venture Capital | Minority | ||
| HMA Capital Partners | Venture Capital | Minority |
RedPath Integrated Pathology FAQs
-
When was RedPath Integrated Pathology founded?
RedPath Integrated Pathology was founded in 2004.
-
Where is RedPath Integrated Pathology headquartered?
RedPath Integrated Pathology is headquartered in Pittsburgh, PA.
-
What is the size of RedPath Integrated Pathology?
RedPath Integrated Pathology has 40 total employees.
-
What industry is RedPath Integrated Pathology in?
RedPath Integrated Pathology’s primary industry is Laboratory Services (Healthcare).
-
Is RedPath Integrated Pathology a private or public company?
RedPath Integrated Pathology is a Private company.
-
What is the current valuation of RedPath Integrated Pathology?
The current valuation of RedPath Integrated Pathology is .
-
What is RedPath Integrated Pathology’s current revenue?
The current revenue for RedPath Integrated Pathology is .
-
How much funding has RedPath Integrated Pathology raised over time?
RedPath Integrated Pathology has raised $11.2M.
-
Who are RedPath Integrated Pathology’s investors?
BlueTree Allied Angels, CID Equity, Eurobio Scientific, Golden Seeds, and HMA Capital Partners are 5 of 11 investors who have invested in RedPath Integrated Pathology.
-
When was RedPath Integrated Pathology acquired?
RedPath Integrated Pathology was acquired on 03-Nov-2014.
-
Who acquired RedPath Integrated Pathology?
RedPath Integrated Pathology was acquired by Interpace Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
